Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 9, 2002
Intraperitoneal mitoxantrone: a feasibility and pharmacokinetic studyD Civalleri, M O Vannozzi, F De Cian, et al.
Clinical Drug Investigation|March 11, 2014
Effect of hyaluronidase on the pharmacokinetics of free and total platinum species after intra-arterial Cisplatin in refractory patients with colorectal liver metastasesD Civalleri, M Esposito, F De Cain, et al.
Cancer|May 15, 1993
In situ lung perfusion with cisplatin. An experimental studyG B Ratto, M Esposito, A Leprini, et al.
Anticancer Research|September 1, 1993
Cis-diamminedichloroplatinum (II)-procaine pharmacokinetic interaction in mice bearing P388 leukemiaM Esposito, M O Vannozzi, M Viale, et al.
Anticancer Research|November 1, 1992
Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochlorideS Cafaggi, M Esposito, B Parodi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patientsM Esposito, M Venturini, M O Vannozzi, et al.
Carcinogenesis|December 1, 1993
Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicityM Esposito, M O Vannozzi, M Viale, et al.
Anticancer Research|April 27, 1999
Mitoxantrone in elderly patients with advanced breast cancer: pharmacokinetics, marrow and peripheral hematopoietic progenitor cellsL Repetto, M O Vannozzi, E Balleari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusionR Lerza, M O Vannozzi, G Tolino, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?M Viale, M O Vannozzi, I Pastrone, et al.
Pageof 3